The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

ASCO-ONS standards for the administration of antineoplastic therapy provide a framework for ensuring patient safety.

The ASCO-ONS standards for administration of antineoplastic therapy provide a comprehensive framework for ensuring patient ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

Game-changer' drug Hiprex is set to be approved for NHS use - but there is still no official guidance for treating chronic UTIs ...

California voters have approved a plan to borrow $10 billion for various climate programs. It will be the state’s largest ...

The selling price is an indication that the FDA’s planned sunsetting of the rare pediatric disease voucher program may be ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

There are limited treatment options so I know this drug will be welcomed by patients. This is the latest treatment NICE has recommended for multiple myeloma, with three other drugs also recommended in ...